Physician profile
Mark A Gersman
NPI 1205839552
$3,086.19
in general payments reported to CMS, 2019-2025
21 companies · $884 in 2025
The $884 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $130 · 2021: $219 · 2022: $324 · 2023: $406 · 2024: $775 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,064.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $657.29 | 2019-2025 | Eylea Hd, Eylea |
| Apellis Pharmaceuticals, INC. | $515.04 | 2022-2025 | Syfovre |
| Astellas Pharma US INC | $308.90 | 2023-2025 | Izervay |
| Alimera Sciences, INC. | $254.10 | 2019-2024 | Iluvien, Yutiq |
| Genentech USA, INC. | $225.25 | 2019-2025 | Vabysmo |
| Abbvie INC. | $222.19 | 2023-2025 | |
| Ocular Therapeutix, INC. | $180.02 | 2024 | Dextenza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $95.27 | 2019-2021 | |
| Ivantis, INC | $86.71 | 2021 | |
| Harrow Eye, LLC | $70.90 | 2024-2025 | Iheezo, Triesence |
| Johnson & Johnson Surgical Vision, INC. | $68.37 | 2019 | |
| Novartis Pharmaceuticals Corporation | $66.33 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $55.49 | 2025 | Iluvien, Yutiq |
| Allergan, INC. | $52.82 | 2019-2020 | |
| Eyepoint US, INC. | $49.14 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $45.06 | 2022-2023 | |
| Bausch & Lomb Americas INC. | $35.55 | 2022-2025 | Xipere |
| Sandoz INC. | $29.92 | 2025 | Cimerli |
| Rayner Intraocular Lenses Limited | $29.34 | 2022 | |
| Biogen, INC. | $23.16 | 2023 | |
| Alcon Vision LLC | $15.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gersman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.